Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
3,350 | $4.15 | $13,903 | 47,030 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-03 4:30 pm |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
555 | $5.64 | $3,130 | 7,255 (Direct) |
View |
| 2024-06-13 Sale |
2024-06-17 7:18 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director |
11,000 | $3.3724 | $37,096 | 33,000 (Direct) |
View |
| 2023-11-29 Sale |
2023-12-01 4:30 pm |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
554 | $11.45 | $6,343 | 7,810 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:01 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director |
10,000 | $3.45 | $34,500 | 44,000 (Direct) |
View |
| 2022-11-29 Sale |
2022-12-01 5:00 pm |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
554 | $22.1 | $12,243 | 7,811 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:10 pm |
Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer |
3,186 | $7.55 | $24,054 | 45,894 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-14 5:57 pm |
Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer |
2,942 | $8.62 | $25,360 | 49,080 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
11,250 | $0 | 47,030 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
378,000 | $0 | 378,000 (Direct) |
View |
| 2024-11-29 Exercise |
2024-12-03 4:30 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
1,875 | $0 | 7,255 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-21 9:17 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director |
27,000 | $0 | 60,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A 2034-02-13 |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2023-11-29 Exercise |
2023-12-01 4:30 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
1,875 | $0 | 7,810 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 9:01 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director |
27,000 | $0 | 44,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 5:00 pm |
N/A 2033-02-13 |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
182,800 | $0 | 182,800 (Direct) |
View |
| 2022-11-29 Exercise |
2022-12-01 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
1,875 | $0 | 7,811 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 5:01 pm |
N/A 2032-06-20 |
Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-17 4:16 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 09:00 am |
N/A 2032-02-10 |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-11-29 Option Award |
2021-11-30 4:26 pm |
N/A 2031-11-28 |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
142,500 | $0 | 142,500 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-19 4:28 pm |
N/A 2031-07-14 |
Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 4:46 pm |
N/A 2031-07-14 |
PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director |
108,721 | $0 | 108,721 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 4:10 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer |
30,000 | $0 | 109,894 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 4:55 pm |
N/A 2031-02-16 |
Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer |
102,000 | $0 | 147,894 (Direct) |
View |